At the Board of Directors meeting held on March 22^nd , 2023, we decided to take part of the preferred stock of Curreio, Inc. in connection with the company’s financing of the capital increase.

Company description:

1. Company name： Curreio Inc.
2. Headquarter： Room 357, South Clinical Research Laboratory, Tokyo University,　7-3-1, Hongo, Bunkyo-ku, TokyoJAPAN
3. Representative： Motoki Nakai, CEO
4. Business： Drug discovery and R & D business based on structural analysis using Cryo-EM
5. Founded： August 2019